Neurocrine biosciences posts q4 eps of $0.35

Neurocrine biosciences reports fourth quarter and full-year 2019 financial results.q4 earnings per share $0.35.q4 non-gaap earnings per share $1.05.q4 earnings per share estimate $0.75 -- refinitiv ibes data.qtrly total revenues $244.1 million versus $131.4 million.sees fy 2020 combined gaap research and development and sg&a expenses $740 million to $770 million.sees fy 2020 combined non-gaap research and development and sg&a expenses $620 million to $650 million.q4 revenue view $230.9 million -- refinitiv ibes data.
NBIX Ratings Summary
NBIX Quant Ranking